M05.271

Clinical Causes: Autoimmune response: The body's immune system mistakenly targets its own blood vessels, leading to inflammation. Long-standing rheumatoid arthritis: Chronic RA increases the risk of developing vasculitis as the disease progresses. Genetic factors: Certain genetic predispositions may influence susceptibility to vasculitis. Environmental triggers: Infections or other environmental influences may contribute, but their role is less well understood.

Key Symptoms: Skin manifestations such as ulcers and purplish spots, especially on the legs and ankles. Swelling, warmth, and redness over affected blood vessels. Joint pain and swelling in the affected ankle and foot. Numbness or tingling sensations in the toes or foot due to nerve involvement. Weakness and fatigue related to systemic inflammation. Possible tissue death (necrosis) if blood flow is severely compromised. Other systemic symptoms like fever, weight loss, and malaise.

Diagnosis Path: Physical examination focusing on skin, joints, and neurologic signs. Blood tests such as ESR (erythrocyte sedimentation rate), CRP (C-reactive protein), and rheumatoid factor to assess inflammation and autoimmune activity. Imaging studies like X-rays or MRI scans of the affected ankle and foot to evaluate joint and tissue damage. Biopsy of affected blood vessels or skin lesions to confirm inflammation and vessel involvement. Nerve conduction studies if neurological symptoms are present.

Treatment Protocols: Immunosuppressive medications such as corticosteroids to reduce inflammation. Disease-modifying antirheumatic drugs (DMARDs) like methotrexate or azathioprine to control rheumatoid arthritis. Biologic agents targeting specific immune pathways, if conventional treatments are insufficient. Wound care and antibiotics for skin ulcers or infections. Pain management strategies to alleviate joint discomfort. Regular monitoring to assess disease activity and treatment response.